Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care

ClinicalTrials.gov ID: NCT03371251

Public ClinicalTrials.gov record NCT03371251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 7:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double-Blind Phase 1b/2 Combined Staggered Multiple Dose Escalation Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care

Study identification

NCT ID
NCT03371251
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Boston Pharmaceuticals
Industry
Enrollment
143 participants

Conditions and interventions

Interventions

  • BOS161721 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 9, 2018
Primary completion
Nov 25, 2020
Completion
Nov 25, 2020
Last update posted
Mar 13, 2022

2018 – 2020

United States locations

U.S. sites
17
U.S. states
9
U.S. cities
17
Facility City State ZIP Site status
Pinnacle Research Group Anniston Alabama 36207
TriWest Research Associates El Cajon California 92020-4124
Valerius Medical Group and Research Center Los Alamitos California 90720-5403
Westlake Medical Research Thousand Oaks California 91360-3994
Clinical Research of West Florida Clearwater Florida 33765-2616
Omega Research Consultants DeBary Florida 32713-2260
Centre for Rheumatology Immunology and Arthritis Fort Lauderdale Florida 33309-1715
Millennium Research Ormond Beach Florida 32174
The Arthritis Center Palm Harbor Florida 34684
Clinical Research of West Florida Tampa Florida 33603
Clinic of Robert Hozman/Clinical Investigation Specialists, Inc. Skokie Illinois 60076-1238
Indiana University School of Medicine Indianapolis Indiana 46202
Aa Mrc Llc Grand Blanc Michigan 48439
June DO PC Lansing Michigan 48910-8595
Joint and Muscle Research Institute Charlotte North Carolina 28204-3130
Ramesh C. Gupta M.D. Memphis Tennessee 38119-5214
Accurate Clinical Research Inc Houston Texas 77089

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03371251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 13, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03371251 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →